Notification That Annual Report Will Be Submitted Late (nt 10-k)
April 18 2018 - 6:08AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
|
FORM 12b-25
|
|
SEC FILE NUMBER
|
|
|
|
|
001-14565
|
|
|
|
|
|
|
|
NOTIFICATION OF LATE FILING
|
|
CUSIP NUMBER
356108100
|
|
|
|
|
|
(Check one):
x
Form 10-K
o
Form 20-F
o
Form 11 -K
o
Form 10-Q
o
Form 10-D
o
Form
N-CEN
o
Form N-CSR
For Period Ended:
February 3, 2018
o
Transition Report
on Form 10-K
o
Transition Report
on Form 20-F
o
Transition Report
on Form 11-K
o
Transition Report
on Form 10-Q
o
Transition Report
on Form N-CEN
For the Transition Period Ended: ___________________________
Read Instruction (on back page) Before Preparing
Form. Please Print or Type.
Nothing in this form shall be construed to
imply that the Commission has verified any information contained herein.
|
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
|
|
|
PART I — REGISTRANT INFORMATION
|
|
Fred’s, Inc.
|
Full Name of Registrant
|
|
N/A
|
Former Name if Applicable
|
|
4300 New Getwell Road
|
Address of Principal Executive Office
(Street and Number)
|
|
Memphis, Tennessee 38118
|
City, State and Zip Code
|
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
x
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
(c)
|
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q,10-D,
N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
Fred’s, Inc. (the “Company”) is delayed in preparing
and filing its Annual Report on Form 10-K for the year ended February 3, 2018 (“Form 10-K”) by the April 19, 2018 filing
due date applicable to accelerated filers. During the fourth quarter of 2017, the Company’s board of directors approved a
plan to actively market for sale the Company’s specialty pharmacy business. The specialty pharmacy business meets the criteria
for “Assets held for Sale” in accordance with Accounting Standards Codification (“ASC”) Topic 360 (ASC
360),
Property, Plant and Equipment
as of February 3, 2018 and, as such, the Company will be presenting the results of
operations for the specialty pharmacy business as discontinued operations in accordance with ASC 205-20,
Results of Operations
– Discontinued Operations
for all periods presented in the Form 10-K. Accordingly, the Company requires additional time
to complete the accounting and reporting processes necessary to satisfy the requirement to reflect the discontinuation of its specialty
pharmacy operations. The Company anticipates that the financial statements will be completed in sufficient time to allow for the filing
of its Form 10-K on or before the fifteenth calendar day following the original filing due date of the Form 10-K.
Forward-Looking Statements
Statements in this notification about the expected timing of
the filing of the 10-K, the marketing for sale of the Company’s specialty pharmacy business and the Company’s results
of operations, other than historical facts, constitute forward-looking statements within the meaning of the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking
statements and any such forward-looking statements are qualified in their entirety by reference to the following cautionary statements.
All forward-looking statements speak only as of the date hereof
and are based on current expectations and involve a number of risks, uncertainties and assumptions that could cause the actual
results to differ materially from such forward-looking statements, including, among other things, the time needed for the Company
to finalize and file its Form 10-K, the ability of the Company to identify a buyer of the specialty pharmacy business and, if a
buyer is identified, the terms and conditions of such transaction, whether such transaction might close, and the impact of such
sale on our business and results of operations. Unless required by law, the Company expressly disclaims any obligation to update
publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
PART IV — OTHER INFORMATION
(1)
|
Name and telephone number of person to contact in regard to this notification
|
|
|
|
Joe Anto
|
|
(901)
|
|
365-8880
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
|
|
(2)
|
Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for
such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
Yes
x
No
o
|
|
|
(3)
|
Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject
report or portion thereof?
Yes
x
No
o
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
It is anticipated that there may be a significant change in the
Company’s results of operations for the year ended February 3, 2018, as compared to the corresponding period for the last
fiscal year, primarily due to the Company’s presentation of the results of operations for the specialty pharmacy business
as discontinued operations in accordance with ASC 205-20,
Results of Operations – Discontinued Operations
. Except
for the removal of the Company’s specialty pharmacy business from continuing operations, the Company anticipates that its
continuing operations for the year ended February 3, 2018 will not differ significantly from the corresponding period for the last
fiscal year, except to the extent already disclosed by the Company in its prior filings.
For the reasons described in part III, the Company requires additional
time to complete the accounting and reporting processes necessary to satisfy the requirement to reflect the discontinuation of
its specialty pharmacy operations, and as such, the Company is unable to provide a reasonable estimate of the changes in results of operations
for the year ended February 3, 2018 from the results of operations for the corresponding period for the last fiscal year.
|
Fred’s, Inc.
|
(Name of Registrant as Specified in Charter)
|
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Date
|
April 17, 2018
|
By.
|
/s/ Joe Anto
|
|
|
|
Name: Joe Anto
Title: Executive Vice President, Chief Financial Officer and Secretary
|
|
|
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.
|
|
ATTENTION
|
|
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
|
|
Freds (NASDAQ:FRED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Freds (NASDAQ:FRED)
Historical Stock Chart
From Apr 2023 to Apr 2024